Checkpoint Therapeutics, Inc. (CKPT)
NASDAQ: CKPT · Real-Time Price · USD
2.430
-0.030 (-1.22%)
Sep 19, 2024, 4:00 PM EDT - Market closed
Checkpoint Therapeutics Market Cap
Checkpoint Therapeutics has a market cap or net worth of $109.39 million as of September 20, 2024. Its market cap has increased by 153.23% in one year.
Market Cap
109.39M
Enterprise Value
104.44M
1-Year Change
153.23%
Ranking
Category
Stock Price
$2.43
Market Cap Chart
Since June 26, 2017, Checkpoint Therapeutics's market cap has decreased from $252.20M to $109.39M, a decrease of -56.62%. That is a compound annual growth rate of -10.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2024 | 110.70M | 105.38% |
| Dec 29, 2023 | 53.90M | 13.47% |
| Dec 30, 2022 | 47.50M | -81.77% |
| Dec 31, 2021 | 260.50M | 44.80% |
| Dec 31, 2020 | 179.90M | 173.82% |
| Dec 31, 2019 | 65.70M | 5.97% |
| Dec 31, 2018 | 62.00M | -37.37% |
| Dec 29, 2017 | 99.00M | -60.75% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PDS Biotechnology | 113.04M |
| ALX Oncology Holdings | 112.72M |
| Veru Inc. | 112.72M |
| FONAR | 112.33M |
| Anixa Biosciences | 111.02M |
| Leap Therapeutics | 110.20M |
| Annovis Bio | 109.13M |
| Verastem | 109.06M |